DDIAX
Price
$15.63
Change
-$0.07 (-0.45%)
Updated
Aug 15 closing price
Net Assets
840.86M
RLBCX
Price
$37.19
Change
-$0.09 (-0.24%)
Updated
Aug 15 closing price
Net Assets
256.26B
Interact to see
Advertisement

DDIAX vs RLBCX

Header iconDDIAX vs RLBCX Comparison
Open Charts DDIAX vs RLBCXBanner chart's image
Macquarie Wealth Builder A
Price$15.63
Change-$0.07 (-0.45%)
VolumeN/A
Net Assets840.86M
American Funds American Balanced R3
Price$37.19
Change-$0.09 (-0.24%)
VolumeN/A
Net Assets256.26B
DDIAX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DDIAX vs. RLBCX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DDIAX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 256B vs. DDIAX (841M). RLBCX pays higher dividends than DDIAX: RLBCX (1.56) vs DDIAX (1.46). DDIAX was incepted earlier than RLBCX: DDIAX (29 years) vs RLBCX (23 years). DDIAX (1.09) is less costly to investors than RLBCX (0.89). DDIAX is a more actively managed with annual turnover of: 66.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than DDIAX: RLBCX (250) vs DDIAX (1000). RLBCX annual gain was more profitable for investors over the last year : 7.61 vs. DDIAX (4.10). RLBCX return over 5 years is better than : 36.26 vs. DDIAX (29.35).
DDIAXRLBCXDDIAX / RLBCX
Total Expense Ratio1.060.89119%
Annual Report Gross Expense Ratio1.090.89122%
Fund Existence29 years23 years-
Gain YTD7.1739.53775%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets841M256B0%
Annual Yield % from dividends1.461.5694%
Returns for 1 year4.107.6154%
Returns for 3 years12.3628.4743%
Returns for 5 years29.3536.2681%
Returns for 10 years36.0763.1857%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UGP3.300.03
+0.92%
Ultrapar Participacoes SA
BBDO2.590.01
+0.39%
Banco Bradesco SA
NEUP8.10N/A
N/A
Neuphoria Therapeutics Inc
AEVA13.10-0.18
-1.36%
Aeva Technologies Inc
USAU11.34-0.33
-2.83%
US Gold Corp